Given the association of deleterious SNPs with diverse diseases, utilizing tolerated SNPs identified in the study—shown to reduce the binding affinity between the protective antigen and ANTXR2 gene—may prove effective as a biomarker against anthrax. This evidence concerns the gene ANTXR2 and anthrax infection.